Lilly, preparing Alzheimer's drug plans, forms new neuroscience unit in company restructure
Bio Pharma Dive
AUGUST 17, 2021
Lilly Bio-Medicines will be split into separate neuroscience and immunology groups, while the Loxo cancer research division will merge with Lilly Oncology.
Let's personalize your content